Surgical treatments for post herpetic neuralgia

Reading File

Finding Sources

Searching PubMed

"postherpetic neuralgia"[MeSH Terms] AND surgical treatment

Reading File

Searching PubMed

"postherpetic neuralgia"[MeSH Terms] AND "spinal cord stimulation"

Reading File

Searching PubMed

"postherpetic neuralgia" AND "neuromodulation"

Finding Sources

Reading Article

Reading File

Searching PubMed

"postherpetic neuralgia" AND "pulsed radiofrequency"

Reading Article

Finding Sources

I now have comprehensive information from multiple textbooks and recent literature. Here is the full synthesis:

Surgical and Interventional Treatments for Postherpetic Neuralgia (PHN)

PHN is defined as pain persisting more than 3 months after healing of the herpes zoster rash. It affects up to 50% of patients over age 50, and its incidence climbs to 30-50% in the elderly. Medical management is the mainstay (gabapentinoids, TCAs, topical lidocaine/capsaicin), but a significant proportion of patients remain refractory. Surgical and interventional options are then considered.

1. Sympathetic Nerve Blocks

Mechanism: Blockade of the sympathetic chain (stellate ganglion for head/neck/upper limb; lumbar sympathetic chain for lower extremities) was historically the most used interventional approach.

Timing is key: When performed within 2 months of rash onset during the acute phase, sympathetic blocks may reduce pain and decrease the incidence of PHN - some studies report resolution in up to 80% of patients. However, once PHN is well established, sympathetic blocks - like most other treatments - are generally ineffective.

Morgan and Mikhail's Clinical Anesthesiology, 7e
Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, p. 4763

2. Epidural Injections (Steroid + Local Anesthetic)

What it involves: Epidural injection of local anesthetics and/or corticosteroids, targeting the affected dermatomal level.

Prospective controlled studies have yielded conflicting results
Epidural steroids have not been proven to prevent PHN
To be effective in preventing PHN, blocks should ideally be performed within 2 weeks of rash onset
Current guidelines (Adriaansen et al., 2024 - Pain Practice) include epidural injection as an option for acute HZ-related pain that is insufficiently controlled
Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, p. 4762-4763
Adriaansen et al., 2024 - Pain Practice [PMID: 39364882]

3. Pulsed Radiofrequency (PRF) of the Dorsal Root Ganglion (DRG)

This is currently considered the most promising interventional treatment for established PHN.

Mechanism: PRF delivers short bursts of radiofrequency energy in a non-destructive, neuromodulatory manner (unlike conventional RFA which ablates tissue). It modulates pain via electric field effects and down-regulation of nociceptive pathways, without causing nerve destruction.

Evidence:

A 2024 RCT (Feng et al., Pain Physician) tested higher-voltage (up to ~86V vs. standard 65V) long-duration PRF for zoster-associated spinal pain. The higher-voltage group had significantly lower VAS scores at 12 weeks, improved quality of life, and reduced pregabalin consumption, with no increase in adverse events. [PMID: 39688827]
A 2025 narrative review (Jitsinthunun et al., Pain Physician) confirmed PRF is effective specifically for radicular pain and PHN, with long-term pain relief and minimal risk [PMID: 41337760]
The 2024 World Institute of Pain guideline update concluded "PRF of the DRG seems to be the most promising interventional management" for PHN [PMID: 39364882]

Targets: Dorsal root ganglion at the affected dermatome(s); trigeminal ganglion (Gasserian) for facial/ophthalmic PHN.

4. Spinal Cord Stimulation (SCS)

SCS involves placing multicontact epidural electrodes in the posterior epidural space, connected to an implantable pulse generator (IPG), to activate inhibitory dorsal column pathways and release inhibitory neurotransmitters.

For PHN specifically:

Listed as an established indication in multiple texts (Tintinalli's Emergency Medicine; Morgan and Mikhail)
Studies show some benefit but are largely retrospective without controls
A 2023 systematic review in Neuromodulation (Zheng et al.) covered neurostimulation for chronic pain including PHN [PMID: 37436342]
A reference cited in Barash (2020) found early temporary SCS effectively prevents PHN development when applied during the acute phase [Barash, p. 4763]
A 2024 single-center study (Chang et al., Clin Neurol Neurosurg) comparing SCS vs. trigeminal semilunar ganglion stimulation (TSGS) for PHN found SCS had a higher satisfaction rate (89% vs. 77%) [PMID: 38981167]

Procedure:

Trial phase: temporary electrodes placed in posterior epidural space and connected to external generator for 5-7 days
If >50% pain relief, a permanent fully implantable system is placed
Effectiveness may decline over time in some patients

Complications: Infection (2.5-5%), lead migration, lead breakage, dural puncture, CSF leak, epidural fibrosis, device failure (17-25%)

Morgan and Mikhail's Clinical Anesthesiology, 7e, pp. 2082-2084
Tintinalli's Emergency Medicine, p. 1227

5. Dorsal Root Ganglion (DRG) Stimulation

A more targeted alternative to SCS. The electrode is placed at the specific DRG level matching the affected dermatome via the lateral aspect of the epidural space.

Particularly effective for well-localized PHN (single or limited dermatomes)
Evidence in CRPS and lower extremity neuropathic pain is strong; PHN applications are emerging
Dual neuromodulation strategies combining DRG stimulation peripherally with SCS centrally have been reported for zoster-associated pain [PMID: 39433895]
Morgan and Mikhail's Clinical Anesthesiology, 7e, p. 2084

6. Peripheral Nerve Stimulation (PNS)

Subcutaneous electrodes placed over the affected peripheral nerve territory. Used for localized PHN not responsive to other measures. Evidence base is largely case reports and small series.

Tintinalli's Emergency Medicine, p. 1227

7. Intrathecal Drug Delivery / Intrathecal Methylprednisolone

Intrathecal methylprednisolone with lidocaine (once weekly x 4 doses) showed promising early results for intractable PHN in one landmark study (Kotani et al., NEJM 2000) - more effective than intrathecal lidocaine alone.

However, a subsequent study attempting to confirm this efficacy was suspended due to lack of efficacy, and given conflicting results and procedural risks, intrathecal steroid is not conclusively recommended for PHN.

Intrathecal drug delivery systems (IDDS) (e.g., intrathecal opioids, ziconotide) may be considered in cancer-related PHN or severe refractory cases.

Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, pp. 2930-2932

8. Ablative Procedures (Historical / Last Resort)

Cordotomy

Percutaneous cervical cordotomy (interruption of the spinothalamic tract) has been used for PHN, particularly in cancer patients with limited life expectancy. Results are variable and dysesthesia can recur.

DREZ Lesioning (Dorsal Root Entry Zone)

Surgical destruction of the dorsal root entry zone targets the area of abnormal neuronal firing responsible for neuropathic pain. Reserved for the most severe, intractable cases (particularly post-herpetic pain in the thoracic dermatomes). Risk of ipsilateral motor deficits limits its use.

Sympathectomy

Surgical or chemical sympathectomy has been used historically but evidence is very limited, and benefits are inconsistent.

Summary Table

Procedure	Best Timing	Evidence Level	Current Role
Sympathetic block	Acute phase (<2 months)	Limited RCTs	Acute prevention of PHN
Epidural steroid/LA	Acute phase (<2 weeks)	Conflicting	Acute HZ pain; controversial
Pulsed radiofrequency (DRG)	Established PHN	Moderate (RCTs)	Most promising interventional Rx
Spinal cord stimulation	Refractory PHN	Retrospective	Established; use after PRF fails
DRG stimulation	Refractory PHN	Emerging	Targeted alternative to SCS
Peripheral nerve stimulation	Localized PHN	Case reports	Adjunct
Intrathecal methylprednisolone	Refractory PHN	Conflicting	Not recommended routinely
DREZ lesioning	Severe refractory	Small series	Last resort
Cordotomy	Cancer-related	Low	Last resort / palliative

Key clinical takeaway: The interventional approach should be matched to timing and severity. During the acute phase, nerve blocks (sympathetic or epidural) may prevent PHN. For established, refractory PHN, pulsed radiofrequency of the dorsal root ganglion now has the strongest evidence base, followed by spinal cord stimulation for patients who fail conservative interventional management. Destructive/ablative procedures are last-resort options given risk of worsening dysesthesia.

This is a shared conversation. Sign in to Orris to start your own chat.